functional dyspepsia
Conditions
Interventions
anti-secretory drug
placebo
Sponsors
Office of the ELF study
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with functional dyspepsia
Exclusion criteria
Exclusion criteria: Patients with organic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of dyspeptic symptoms by symptomatic scale and GSRS | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' background anti-H. pylori IgG | — |
Countries
Japan
Contacts
Public ContactNaoki Tomotsugu, Ph.D.
Keio University School of Medicine Center for Clinical Research
Outcome results
None listed